Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France · Delayed Price · Currency is EUR 0.3800
+0.0010 (0.26%)
At close: Oct 2, 2026
EPA:ALOPM Market Cap
EPA:ALOPM has a market cap or net worth of €7.22 million as of October 2, 2026. Its market cap has decreased by -27.52% in one year.
Market Cap
7.22M
Enterprise Value
11.48M
Revenue
1.81M
Ranking
n/a
PE Ratio
1.26
Stock Price
€0.38
ChartMarket Cap Chart
Since October 5, 2022, EPA:ALOPM's market cap has increased from 5.82M to 7.22M, an increase of 23.91%. That is a compound annual growth rate of 5.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 7.22M | -3.35% |
| Dec 31, 2025 | 7.47M | -42.44% |
| Dec 31, 2024 | 12.97M | -56.74% |
| Dec 29, 2023 | 29.99M | 155.14% |
| Dec 30, 2022 | 11.75M | 101.80% |
| Oct 5, 2022 | 5.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 19.63M |
| MaaT Pharma | 19.03M |
| Biophytis | 15.86M |
| Aelis Farma | 12.02M |
| Advicenne | 9.75M |
| TME Pharma | 9.69M |
| Aton | 9.61M |
| Poxel | 8.94M |